160 related articles for article (PubMed ID: 18851895)
1. Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells.
Park KS; Han BG; Lee KH; Kim DS; Kim JM; Jeon H; Kim HS; Suh SW; Lee EH; Kim SY; Lee BI
Cancer Lett; 2009 Feb; 274(2):201-7. PubMed ID: 18851895
[TBL] [Abstract][Full Text] [Related]
2. Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.
Kim DS; Park KS; Jeong KC; Lee BI; Lee CH; Kim SY
Cancer Lett; 2009 Jan; 273(2):243-9. PubMed ID: 18804908
[TBL] [Abstract][Full Text] [Related]
3. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
[TBL] [Abstract][Full Text] [Related]
4. A new regulatory mechanism of NF-kappaB activation by I-kappaBbeta in cancer cells.
Kim JM; Voll RE; Ko C; Kim DS; Park KS; Kim SY
J Mol Biol; 2008 Dec; 384(4):756-65. PubMed ID: 18950638
[TBL] [Abstract][Full Text] [Related]
5. Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation.
Kim DS; Park SS; Nam BH; Kim IH; Kim SY
Cancer Res; 2006 Nov; 66(22):10936-43. PubMed ID: 17108131
[TBL] [Abstract][Full Text] [Related]
6. Antisense inhibition of transglutaminase 2 affects development of mouse embryo submandibular gland in organ culture.
Lee SK; Kim YS; Lee SS; Lee YJ; Song IS; Park SC; Chi JG; Chung SI
Arch Oral Biol; 2005 Sep; 50(9):789-98. PubMed ID: 15970210
[TBL] [Abstract][Full Text] [Related]
7. The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway.
Jiang WG; Ablin RJ; Kynaston HG; Mason MD
Microvasc Res; 2009 Mar; 77(2):150-7. PubMed ID: 18983858
[TBL] [Abstract][Full Text] [Related]
8. Depletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survival.
Kim SJ; Kim KH; Ahn ER; Yoo BC; Kim SY
Amino Acids; 2013 Jan; 44(1):73-80. PubMed ID: 21960143
[TBL] [Abstract][Full Text] [Related]
9. I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway.
Kim DS; Han BG; Park KS; Lee BI; Kim SY; Bae CD
Biochem Biophys Res Commun; 2010 Aug; 399(2):300-6. PubMed ID: 20659425
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2 activity promotes membrane resealing after mechanical damage in the lung cancer cell line A549.
Kawai Y; Wada F; Sugimura Y; Maki M; Hitomi K
Cell Biol Int; 2008 Aug; 32(8):928-34. PubMed ID: 18474442
[TBL] [Abstract][Full Text] [Related]
11. GTP is required to stabilize and display transamidation activity of transglutaminase 2.
Jeon JH; Cho SY; Kim CW; Shin DM; Kweon JC; Choi KH; Park SC; Kim IG
Biochem Biophys Res Commun; 2002 Jun; 294(4):818-22. PubMed ID: 12061780
[TBL] [Abstract][Full Text] [Related]
12. Tissue transglutaminase-induced down-regulation of matrix metalloproteinase-9.
Ahn JS; Kim MK; Hahn JH; Park JH; Park KH; Cho BR; Park SB; Kim DJ
Biochem Biophys Res Commun; 2008 Nov; 376(4):743-7. PubMed ID: 18809380
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma.
Ku BM; Kim DS; Kim KH; Yoo BC; Kim SH; Gong YD; Kim SY
FASEB J; 2013 Sep; 27(9):3487-95. PubMed ID: 23704086
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid induces transglutaminase II to enhance cell motility; role of Rac1 and FAK in the induction of transglutaminase II.
Kim Y; Park YW; Lee YS; Jeoung D
Biotechnol Lett; 2008 Jan; 30(1):31-9. PubMed ID: 17680210
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of transglutaminase II leads to impaired motility of cancer cells by inactivation of the protein kinase, Akt, and decrease of reactive oxygen species.
Bae J; Lee YS; Jeoung D
Biotechnol Lett; 2006 Aug; 28(15):1151-8. PubMed ID: 16807769
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of high-molecular-weight protein polymers in a doxorubicin-resistant breast-cancer cell line.
Park SS; Kim DS; Park KS; Song HJ; Kim SY
Proteomics Clin Appl; 2007 Jun; 1(6):555-60. PubMed ID: 21136706
[TBL] [Abstract][Full Text] [Related]
17. Detection of in situ activation of transglutaminase during apoptosis: correlation with the cell cycle phase by multiparameter flow and laser scanning cytometry.
Grabarek J; Ardelt B; Kunicki J; Darzynkiewicz Z
Cytometry; 2002 Oct; 49(2):83-9. PubMed ID: 12357464
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase 2 expression in the salivary myoepithelial cells of mouse embryo.
Lee SK; Kim YS; Lee YJ; Lee SS; Song IS; Park SC; Chi JG; Chung SI
Arch Oral Biol; 2005 Mar; 50(3):301-8. PubMed ID: 15740708
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy.
Kang JH; Lee JS; Hong D; Lee SH; Kim N; Lee WK; Sung TW; Gong YD; Kim SY
Cell Death Dis; 2016 Mar; 7(3):e2163. PubMed ID: 27031960
[TBL] [Abstract][Full Text] [Related]
20. Tissue transglutaminase-mediated glutamine deamidation of beta-amyloid peptide increases peptide solubility, whereas enzymatic cross-linking and peptide fragmentation may serve as molecular triggers for rapid peptide aggregation.
Schmid AW; Condemi E; Tuchscherer G; Chiappe D; Mutter M; Vogel H; Moniatte M; Tsybin YO
J Biol Chem; 2011 Apr; 286(14):12172-88. PubMed ID: 21300794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
